Marra, Robelin .

HRN: 25-94-21  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/24/2024
CEFUROXIME 1.5GM (VIAL)
09/24/2024
09/24/2024
IV
1.4gm
LD
Cs Eclapmsia
Waiting Final Action 
09/24/2024
CEFUROXIME 1.5GM (VIAL)
09/24/2024
09/25/2024
IV
1.5gm
Q8
Post Cs
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: